Cargando…
Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
Objectives: Pre-existing or new diabetes confers an adverse prognosis in people with Covid-19. We reviewed the clinical literature on clinical outcomes in metformin-treated subjects presenting with Covid-19. Methods: Structured PubMed search: metformin AND [covid (ti) OR covid-19 (ti) OR covid19 (ti...
Autores principales: | Bailey, Clifford J., Gwilt, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964397/ https://www.ncbi.nlm.nih.gov/pubmed/35370738 http://dx.doi.org/10.3389/fphar.2022.784459 |
Ejemplares similares
-
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
por: Hostalek, Ulrike, et al.
Publicado: (2015) -
Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
por: Tan, Jixue, et al.
Publicado: (2021) -
Development and Evaluation of Novel Metformin Derivative Metformin Threonate for Brain Ischemia Treatment
por: Zhang, Gufang, et al.
Publicado: (2022) -
Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans
por: Rotroff, Daniel M., et al.
Publicado: (2016) -
Literature review of the clinical characteristics of metformin-induced hepatotoxicity
por: Wang, Chunjiang, et al.
Publicado: (2022)